An Innovative Balloon-Type Surgical Device for Atrial Fibrillation
DOI:
https://doi.org/10.1532/HSF98.20041141Abstract
Background. The maze procedure and its modifications are the surgical treatment for atrial fibrillation. In an attempt to achieve a less invasive operation, we developed a balloon-type device for electric pulmonary vein isolation and evaluated its effectiveness macroscopically and microscopically.
Methods. We created a left heart system model from 20 pigs. Based on a mold, a balloon was made with silicone resin. When this balloon was inflated, all pulmonary vein orifices were pressed and ablated by probes using radiofrequency and cryotherm as energy sources. Macroscopic and microscopic evaluations were performed.
Results. Complete circular ablation by radiofrequency was confirmed in 2 of 3 veins. The transmural denaturation was pathologically confirmed in all areas ablated at 80 for 2 minutes. The complete circular ablation line and the transmural denaturation were macroscopically and microscopically confirmed after cryoablation at -100 degrees for 2 minutes using liquid nitrogen.
Conclusions. This study proved that the balloon is effective in simplifying pulmonary vein isolation and has potential to become an instrument that contributes to less invasive operations in the near future.
References
Tanaka K, Satake S, Saito S, et al. 2001. A new radiofrequency thermal balloon catheter for pulmonary vein isolation. J Am Coll Cardiol 38:2079-86.nMaessen JG, Nijs JF, Smeets JL. et al. 2002. Beating-heart surgical treatment of atrial fibrillation with microwave ablation. Ann Thorac Surg 74:S1307-11.nCox JL, Ad N, Palazzo T, et al. 2000. Current status of the Maze procedure for the treatment of atrial fibrillation. Semin Thorac Cardiovasc Surg 12:15-9.nGillinov AM, Blackstone EH, McCarthy PM. 2002. Atrial fibrillation: current surgical options and their assessment [review]. Ann Thorac Surg 74:2210-17.nGillinov AM, McCarthy PM. 2002. Atricure bipolar radiofrequency clamp for intraoperative ablation of atrial fibrillation. Ann Thorac Surg 74:2165-8.nGuiraudon GM. 1987. Cryoablation, a versatile tool in arrhythmia surgery. Ann Thorac Surg 43:129-30.nCox JL. 1995. The modification of the maze procedure for atrial flutter and atrial fibrillation. I. J Thorac Cardiovasc Surg 110:473-84.nShepherd J, Dawber RP. 1982. The historical and scientific basis of cryosurgery. Clin Exp Dermatol 7:321-8.nOtt DA, Garson A, Cooley DA, Smith RT, Moak J. 1987. Cryoablative techniques in the treatment of cardiac tachyarrhythmias. Ann Thorac Surg 43:138-43.nKhairy P, Chauvet P, Lehmann J, et al. 2003. Lower incidence thrombus formation with cryoenergy versus radiofrequency catheter ablation. Circulation 107:2045-50.nKeane D, Ruskin JN. 1999. Linear atrial ablation with a diode laser and fiberoptic catheter. Circulation 100:e59-60.nCox JL. 1991. The surgical treatment of atrial fibrillation. IV. Surgical technique. J Thorac Cardiovasc Surg 101:584-92.nJais P, Weerasooriya R, Shah DC, et al. 2002. Ablation therapy for atrial fibrillation (AF): past, present and future. Cardiovasc Res 54:337-46.nSie HT, Beukema WP, Ramdat Misier AR, Elvan A, Ennema JJ, Wellens HJ. 2001. The radiofrequency modified maze procedure. A less invasive surgical approach to atrial fibrillation during open-heart surgery. Eur J Cardiothorac Surg 19:443-7.nSpitzer SG, Richter P, Kaunt M, Schuler S. 1999. Treatment of atrial fibrillation in open heart surgery-the potential role of microwave energy [review]. Thorac Cardiovasc Surg 3(Suppl):374-8.nRoithinger FX, Steiner PR, Goseki Y, Sparks PB, Lesh MD. 1999. Electrophysiologic effects of selective right versus left atrial linear lesions in a canine model of chronic atrial fibrillation. J Cardiovasc Electrophysiol 10:1564-74.nChen SA, Hsieh MH, Tai CT, et al. 1999. Initiation of atrial fibrillation by ectopic beats originating from pulmonary veins: electrophysiological characteristics, pharmacological response, and effect of radiofrequency ablation. Circulation 100:1879-86.nGaita F, Riccardi R, Calo L, et al. 1998. Atrial mapping and radiofrequency catheter ablation in patients with idiopathic atrial fibrillation. Electrophysiological findings and ablation results. Circulation 97:2136-45.nPrasad SM, Maniar HS, Schuessler RB, Damiano RJ. 2002. Chronic transmural atrial ablation by using bipolar radiofrequency energy on the beating heart. J Thorac Cardiovasc Surg 124:708-13.nVigilance DW, Williams M, Garrido M, et al. 2003. Atrial fibrillation surgery using linear laser technology [abstract]. Heart Surg Forum 6:121.nWonnell TL, Stauffer PR, Langberg JJ. 1992. Evaluation of microwave and radiofrequency ablation in a myocardium-equivalent phantom model. IEEE Trans Biomed Eng 39:1086-95.nNatale A, Posano E, Shewchik J, et al. 2000. First human experience with pulmonary vein isolation using a through-the-balloon circumferential ultrasound ablation system for recurrent atrial fibrillation. Circulation 102:1879-82.nIzuminoto H, Kawazoe K, Eishi K, Kamata J. 2000. Medium-term results after the modified Cox/Maze procedure combined with other cardiac surgery. Eur J Cardiothorac Surg 17:25-9.nHaissaguerre M, Lais P, Shah DC, et al. 1996. Right and left atrial radiofrequency catheter therapy of paroxysmal atrial fibrillation. J Cardiovasc Electrophysiol 7:1132-44.nKlein GJ, Harrison L, Ideker RF, et al. 1979. Reaction of the myocardium to cryosurgery: electrophysiology and arrhythmogenic potential. Circulation 59:364-72.nHaissaguerre M. 1998. Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. New Eng J Med 339:659-66.nMazzitelli D, Park CH, Park KY. et al. 2002. Epicardial ablation of atrial fibrillation on the beating heart without cardiopulmonary bypass. Ann Thorac Surg 73:320-1.nNitta T, Lee R, Schuessler RB, Boineau JP, Cox JL. 1999. Radial approach: a new concept in surgical treatment for atrial fibrillation I. Concept, anatomic and physiologic bases and development of procedure. Ann Thorac Surg 67:27-35.n
Published
How to Cite
Issue
Section
Author Disclosure & Copyright Transfer Agreement
In order to publish the original work of another person(s), The Heart Surgery Forum® must receive an acknowledgment of the Author Agreement and Copyright Transfer Statement transferring to Forum Multimedia Publishing, L.L.C., a subsidiary of Carden Jennings Publishing Co., Ltd. the exclusive rights to print and distribute the author(s) work in all media forms. Failure to check Copyright Transfer agreement box below will delay publication of the manuscript.
A current form follows:
The author(s) hereby transfer(s), assign(s), or otherwise convey(s) all copyright ownership of the manuscript submitted to Forum Multimedia Publishing, LLC (Publisher). The copyright transfer covers the exclusive rights to reproduce and distribute the article and the material contained therein throughout the world in all languages and in all media of expression now known or later developed, including but not limited to reprints, photographic reproduction, microfilm, electronic data processing (including programming, storage, and transmission to other electronic data record(s), or any other reproductions of similar nature), and translations.
However, Publisher grants back to the author(s) the following:
- The right to make and distribute copies of all or part of this work for use of the author(s) in teaching;
- The right to use, after publication in The Heart Surgery Forum, all or part of the material from this work in a book by the author(s), or in a collection of work by the author(s);
- The royalty-free right to make copies of this work for internal distribution within the institution/company that employs the author(s) subject to the provisions below for a work-made-for-hire;
- The right to use figures and tables from this work, and up to 250 words of text, for any purpose;
- The right to make oral presentations of material from this work.
Publisher reserves the right to grant or refuse permission to third parties to republish all or part of the article or translations thereof. To republish, such third parties must obtain written permission from the Publisher. (This is in accordance with the Copyright Statute, United States Code, Title 17. Exception: If all authors were bona fide officers or employees of the U.S. Government at the time the paper was prepared, the work is a “work of the US Government” (prepared by an officer or employee of the US Government as part of official duties), and therefore is not subject to US copyright; such exception should be indicated on signature lines. If this work was prepared under US Government contract or grant, the US Government may reproduce, royalty-free, all or portions of this work and may authorize others to do so, for official US Government purposes only, if the US Government contract or grant so requires.
I have participated in the conception and design of this work and in the writing of the manuscript and take public responsibility for it. Neither this manuscript nor one with substantially similar content under my authorship has been published, has been submitted for publication elsewhere, or will be submitted for publication elsewhere while under consideration by The Heart Surgery Forum, except as described in an attachment. I have reviewed this manuscript (original version) and approve its submission. If I am listed above as corresponding author, I will provide all authors with information regarding this manuscript and will obtain their approval before submitting any revision. I attest to the validity, accuracy, and legitimacy of the content of the manuscript and understand that Publisher assumes no responsibility for the validity, accuracy, and legitimacy of its content. I warrant that this manuscript is original with me and that I have full power to make this Agreement. I warrant that it contains no matter that is libelous or otherwise unlawful or that invades individual privacy or infringes any copyright or other proprietary right. I agree to indemnify and hold Publisher harmless of and from any claim made against Publisher that relates to or arises out of the publication of the manuscript and agree that this indemnification shall include payment of all costs and expenses relating to the defense of any such claim, including all reasonable attorney’s fees.
I warrant that I have no financial interest in the drugs, devices, or procedures described in the manuscript (except as disclosed in the attached statement).
I state that the institutional Human Subjects Committee and/or the Ethics Committee approved the clinical protocol reported in this manuscript for the use of experimental techniques, drugs, or devices in human subjects and appropriate informed consent documents were utilized.
Furthermore, I state that any and all animals used for experimental purposes received humane care in USDA registered facilities in compliance with the “Principles of Laboratory Animal Care” formulated by the National Society for Medical Research and the “Guide for the Care and Use of Laboratory Animals” prepared by the Institute of Laboratory Animal Resources and published by the National Institutes of Health (NIH Publication No. 85-23, revised 1985).
